Form 4: National Health Investors SVP/Chief Accounting Officer Acquires Shares and Stock Options
SEC Filing
David L. Travis, SVP/Chief Accounting Officer of National Health Investors, acquired 5,500 shares of common stock and multiple tranches of stock options.
Summary
- On March 3, 2025, David L. Travis, SVP/Chief Accounting Officer of National Health Investors Inc. (NHI), acquired 5,500 shares of common stock.
- These shares were acquired at a price of $0 and are restricted stock vesting 20% annually starting March 3, 2026.
- Following the transaction, Travis directly owns 21,555 shares of NHI common stock.
- Travis also acquired multiple tranches of stock options with an exercise price of $73.34, expiring on March 3, 2030.
- These options vest annually from March 3, 2025, to March 3, 2027.
- Travis also holds various other stock options granted in previous years with exercise prices ranging from $53.41 to $69.2 and expiration dates in 2026, 2027, 2028 and 2029.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. The acquisition of shares by an executive is generally a good sign, but it's a routine filing and doesn't necessarily indicate a major shift in the company's prospects.
Positives
- The acquisition of shares by a key executive could be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Form 4 filings are standard disclosures for corporate insiders and provide transparency into their transactions in the company's securities.
Comparison to Industry Standards
- Comparing Travis's stock option grants to those of executives at similar REITs like Welltower (WELL) or Ventas (VTR) would provide context on whether the size and terms of the grants are typical.
- Analyzing the vesting schedules and exercise prices relative to the company's stock performance can indicate alignment with shareholder interests.
- Benchmarking the percentage of equity ownership by insiders against industry averages can reveal how incentivized management is to drive long-term value.
Stakeholder Impact
- The acquisition of shares by an executive could increase investor confidence.
- The vesting of restricted stock and stock options aligns the executive's interests with those of shareholders.
Key Dates
| Date | Description |
|---|---|
| 02/25/2021 | Grant date of stock options with an exercise price of $69.2 and expiration date of 02/25/2026. |
| 02/25/2022 | Grant date of stock options with an exercise price of $53.41 and expiration date of 02/25/2027. |
| 02/24/2023 | Grant date of stock options with an exercise price of $54.73 and expiration date of 02/24/2028. |
| 02/23/2024 | Grant date of stock options with an exercise price of $57.76 and expiration date of 02/23/2029. |
| 03/03/2025 | Date of the reported transaction: acquisition of common stock and stock options. |
| 03/03/2026 | First vesting date (20%) for the acquired restricted stock. |
| 02/25/2026 | Expiration date of stock options granted on 02/25/2021. |
| 03/03/2030 | Expiration date of stock options acquired on 03/03/2025. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.